bioMérieux - First-Half 2015 Business Review

MARCY L'ETOILE – July 17, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the six months ended June 30, 2015.

Fast-rising sales in the Americas, up 18.3%, and a return to more sustained expansion in the Asia-Pacific, up 6.6%

• Robust demand in the priority areas for growth
• FilmArray® sales doubled year-on-year, installed base expanded to nearly 1,900 instruments
• Solid 5.0% gain in clinical microbiology
• Sustained 7.4% improvement in VIDAS® sales
• Satisfactory 4.4% growth in industrial applications

Alexandre Mérieux, Chief Executive Officer, said: "In the first half of 2015, bioMérieux delivered a fast 8.1% increase in sales on a like-for-like basis. The first six months attest to continued strong sales momentum in North America and robust performances in our main strategic businesses. In particular, FilmArray® continued to demonstrate remarkable success by doubling its sales over the period. It once again fulfilled its role as a driver of faster growth for the Group and strengthened its leadership in the syndromic diagnosis of infectious diseases. The period saw signs of a gradual return to more energetic growth in China. As a result, we are confirming the 2015 organic sales growth objective set earlier this year."

Download the Full Press Release: